News
Market and company headlines
EBSAll
Loading
03:00-08:00Oct 162 Stories
Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl
GAITHERSBURG, Md., October 16, 2026--Emergent BioSolutions Inc. (NYSE: EBS) today announced that Richard S. Lindahl, executive vice president, chief financial officer, will retire from the Company effective December 31, 2026. Frank Vargo, vice president, treasurer, will assume the role of interim chief financial officer effective January 1, 2027. To support a seamless transition, Rich will serve as a senior executive advisor from January 1 through March 31, 2027.
Emergent Biosolutions Appoints Treasurer Frank Vargo As Interim CFO, Effective Jan. 1, 2027, Succeeding Richard Lindahl
https://www.sec.gov/ix?doc=/Archives/edgar/data/1367644/000136764426000098/ebs-20261016.htm
08:00-17:00Oct 152 Stories
Bioscience Association Manitoba Welcomes New Board Members and Executive Members at Annual General Meeting
WINNIPEG, Manitoba, October 15, 2026--The Bioscience Association Manitoba (BAM) is pleased to announce the appointment of new members to its Board of Directors and Executive Board, following the organization’s Annual General Meeting held on October 15, 2026.
Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026
GAITHERSBURG, Md., October 15, 2026--Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, November 2, 2026, at 5:00 p.m. eastern time to discuss the financial results for the third quarter of 2026.